On Tuesday, 4 February 2024, noted that “WHO’s technical support in technology transfer is not adequately reflected” in the current Executive Board documentation on Financing and implementation of the Programme budget 2024–2025. Bangladesh’s full statement is reproduced below. Item 23.1… Continue Reading →
Revised May 6, 2024 Against the backdrop of the tortuous negotiations among WHO Member States on technology transfer and know-how at the last mile of the pandemic agreement talks, on Wednesday, 1 May 2024, Switzerland offered a surprise amendment in… Continue Reading →
I’m in a two day meeting in Geneva on new approaches to affordable monoclonal antibodies (mAbs), and it made me think of a provision found in some bills that have been proposed or introduced in the U.S. Congress to force… Continue Reading →
1994. The 1994 NIH Report on CRADAs and the Reasonable Pricing Clause 1994. September 8. James Love. Pricing of Drugs Developed with Public Funds. Comments Presented to the Second NIH CRADA Forum. 1995. April 11. NIH Notice Rescinding the Reasonable… Continue Reading →